Clever Leaves And Praetorian Team Up To Produce Cannabis Genetics In Colombia

Clever Leaves Holdings Inc. CLVR CLVRW announced its commercial agreement with US-based Praetorian Global Inc., to produce cannabis flower and downstream products from Clever Leaves cultivation facility in Colombia for distribution globally. Flower products resulting from the partnership will be available by Q2 2024 to medical cannabis patients globally, including the European Union, United Kingdom, and Australia.

Beginning in early-2022, Praetorian launched its genetic licensing line of business and currently has executed agreements with licensees whose total global canopy exceeds 8 million square feet. By the end of 2023, Praetorian currently expects that its products will be sold across four continents.

Under the agreement, Clever Leaves and Praetorian will select specific strains for initial trials at the company’s Colombian cultivation, from which the R&D team at Clever Leaves will be able to further progress in its product portfolio, offering a more diverse variety of carefully characterized cannabis solutions for medicinal purposes around the world.

“Our partnership with Praetorian will enable us to come together and produce the best genetics through Colombia’s prime cultivation conditions and the utilization of innovative technology with support from Praetorian. We are thrilled to be working with one of the most prominent names in the U.S. cannabis industry to produce high-quality cannabis genetics, which continues to be a key priority for Clever Leaves,” stated Andrés Fajardo, CEO of the company. “We are aligned with Praetorian in our plans to grow our R&D efforts and our dedication to providing an elevated experience with the best cannabis products for patients.”

Photo: Benzinga edit with photos by geralt and lindsayfox on Pixabay

Related News

Clever Leaves Reports Fourth Quarter And Full Year 2022 Results